108 related articles for article (PubMed ID: 4304555)
21. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
[TBL] [Abstract][Full Text] [Related]
22. Recent and current investigations of radiation therapy of malignant gliomas.
Nelson DF; Urtasun RC; Saunders WM; Gutin PH; Sheline GE
Semin Oncol; 1986 Mar; 13(1):46-55. PubMed ID: 3082011
[No Abstract] [Full Text] [Related]
23. [Treatment of malignant brain tumors by BAR therapy].
Hoshino T
No To Shinkei; 1968 Jun; 20(6):601-11. PubMed ID: 4301942
[No Abstract] [Full Text] [Related]
24. [Clinical and experimental results of interstitial Brachy-Curie-therapy combined with radiation sensitizing agents in infiltrative growing brain neoplasms].
Mundinger F; Vogt P; Jobski C; Fischer HU; Ostertag C
Strahlentherapie; 1972 Mar; 143(3):318-28. PubMed ID: 5053646
[No Abstract] [Full Text] [Related]
25. [Combined treatment of glyal and metastatic tumors of the brain].
Fadeev BP; Zhabina RM
Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
[TBL] [Abstract][Full Text] [Related]
26. [The radiation therapy of experimental brain tumors by using the radiosensitizing preparation xanthobin (8-bromocaffeine)].
Vartanian LP; Rudenko IIa; Volchkov VA
Med Radiol (Mosk); 1989 Nov; 34(11):82-3. PubMed ID: 2586265
[No Abstract] [Full Text] [Related]
27. [Trial and results of improved radiotherapy for cancer. 5. Radiotherapy with simultaneous administration of radio-sensitizing agents. Administration of halogenated pyrimidine].
Tanaka N; Takahashi M
Nihon Rinsho; 1972 Dec; 30(12):2655-8. PubMed ID: 4675997
[No Abstract] [Full Text] [Related]
28. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
Epstein AH; Cook JA; Goffman T; Glatstein E
BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703
[No Abstract] [Full Text] [Related]
29. A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme.
Julka PK; Awasthy BS; Rath GK; Agarwal S; Varna T; Mahapatra AK; Singh R
Australas Radiol; 2000 Feb; 44(1):84-7. PubMed ID: 10761264
[TBL] [Abstract][Full Text] [Related]
30. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.
Stewart DJ; Leavens M; Maor M; Feun L; Luna M; Bonura J; Caprioli R; Loo TL; Benjamin RS
Cancer Res; 1982 Jun; 42(6):2474-9. PubMed ID: 6280860
[No Abstract] [Full Text] [Related]
31. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Sano K; Hoshino T; Nagai M
J Neurosurg; 1968 Jun; 28(6):530-8. PubMed ID: 4233585
[No Abstract] [Full Text] [Related]
32. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
33. Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme.
Choi J; Kim G; Cho SB; Im HJ
J Nanobiotechnology; 2020 Sep; 18(1):122. PubMed ID: 32883290
[TBL] [Abstract][Full Text] [Related]
34. A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
Kinsella TJ; Russo A; Mitchell JB; Rowland J; Jenkins J; Schwade J; Myers CE; Collins JM; Speyer J; Kornblith P
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):69-76. PubMed ID: 6321412
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy for glioblastoma: is costly better?
Linz U
Cancer; 2008 Nov; 113(10):2617-22. PubMed ID: 18833584
[No Abstract] [Full Text] [Related]
36. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
[TBL] [Abstract][Full Text] [Related]
37. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
[TBL] [Abstract][Full Text] [Related]
38. The combined treatment of glioblastoma multiforme.
Gorácz I
Minerva Neurochir; 1969; 13(3):248-50. PubMed ID: 4315378
[No Abstract] [Full Text] [Related]
39. Whole-brain radiotherapy in the management of brain metastasis.
Khuntia D; Brown P; Li J; Mehta MP
J Clin Oncol; 2006 Mar; 24(8):1295-304. PubMed ID: 16525185
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
Phuphanich S; Levin EM; Levin VA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
